Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Titel:
Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Auteur:
Apostol, George Abi-Saab, Walid Kratochvil, Christopher J. Adler, Lenard A. Robieson, Weining Z. Gault, Laura M. Pritchett, Yili L. Feifel, David Collins, Michelle A. Saltarelli, Mario D.